Applicability of Western protocols in resource‐limited setting: Real‐world data of long‐term outcome of intensive treatment of adult acute myeloid leukaemia in Sri Lanka
Saman Hewamana,
Lakmali Kandabadage,
Thurairajah Skandarajah,
Natasha Pieris,
Eranga Perera,
Mahesh Harischandra,
Ananda Wijewickrama,
Chandana Wickramarathna,
Gnani Somasundaram,
Vadivelu Srinivasan,
Surjit Somiah,
Priyankara Jayawardena,
Mehendra Perera,
Dehan Gunasekera,
Chathuri Jayasinghe,
Godvin Constantine,
Sanjeewa Munasinghe,
Chandu De Silva,
Bandula Wijesiriwardena,
Jayantha Balawardena
Affiliations
Saman Hewamana
Clinical Haematology Unit Lanka Hospitals Colombo Sri Lanka
Lakmali Kandabadage
Clinical Haematology Unit Lanka Hospitals Colombo Sri Lanka
Thurairajah Skandarajah
National Cancer Institute Colombo Sri Lanka
Natasha Pieris
Asiri Surgical Hospital Colombo Sri Lanka
Eranga Perera
Asiri Surgical Hospital Colombo Sri Lanka
Mahesh Harischandra
Lanka Hospitals Colombo Sri Lanka
Ananda Wijewickrama
National Institute of Infectious Disease Angoda Sri Lanka
Chandana Wickramarathna
Faculty of Medicine University of Ruhuna Matara Sri Lanka
Gnani Somasundaram
Lanka Hospitals Colombo Sri Lanka
Vadivelu Srinivasan
Lanka Hospitals Colombo Sri Lanka
Surjit Somiah
Lanka Hospitals Colombo Sri Lanka
Priyankara Jayawardena
National Hospital of Sri Lanka Colombo Sri Lanka
Mehendra Perera
National Cancer Institute Colombo Sri Lanka
Dehan Gunasekera
National Cancer Institute Colombo Sri Lanka
Chathuri Jayasinghe
University of Sri Jayewardenepura Colombo Sri Lanka
Godvin Constantine
National Hospital of Sri Lanka Colombo Sri Lanka
Sanjeewa Munasinghe
Army Hospital Colombo Sri Lanka
Chandu De Silva
Faculty of Medicine University of Colombo Colombo Sri Lanka
Bandula Wijesiriwardena
Lanka Hospitals Colombo Sri Lanka
Jayantha Balawardena
Sir John Kotelawala Defence University, Werahera Colombo Sri Lanka
Abstract There are no published data on long‐term survival and applicability of treatment protocols from developed countries in acute myeloid leukaemia (AML) in Sri Lanka. Eighty‐seven AML patients were reviewed; there were 56 newly diagnosed patients between 18 and 65 years. Thirty‐one out of 33 who started treatment achieved complete remission after first cycle of treatment. The induction mortality was one of 33. Twelve out of 20 patients who completed treatment are alive at the time of analysis. The estimated 5‐year overall survival rate is 0.629. Strict infection control and treatment and superior clinical experience may have contributed towards better outcome.